Keywords
use disorder
intranasal
bipolar disorder
Abstract
Anti-cholinergic drugs carry dependency risk. Cyclopentolate is a topical anticholinergic drug commonly used in ophthalmology clinics which possesses mydriatic and cycloplegic properties. A 28 year old male patient previously diagnosed with bipolar disorder was admitted to the psychiatric clinic with symptoms of depression. We learned that he has been using cylo-pentolate containing eye drops intranasally for pleasure for about one year. Hereby, we have reported a cyclopentolate use disorder case with comorbid bipolar disorder, which used cyclopentolate intranasally, different to other cases in the literature.
References
Pullen GP, Best NR, Maguire J. Anticholinergic drug abuse: a common problem. British Medical Journal 1984; 289: 612-613.
Espi Martinez F, Espi Forcen F, Shapov A, Martinez Moya A. Biperiden dependence: case report and literature review. Case Rep Psychiatry 2012; 2012: 949256.
Buhrich N, Weller A, Kevans P. Misuse of anticholinergic drugs by people with serious mental illness. Psychiatry Serv 2000; 51: 928-929.
Gjerden P, Bramness JG, Slordal L. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. Br J Clin Pharmacol 2008; 67: 228-233.
Ağın H, Gerçek H, Kutlu A, ve ark. Delirium induced by topical cyclopentolate use: a case report. Çocuk Sağlığı ve Hastalıkları Dergisi 2008; 51: 39-42.
Ostler HB. Cycloplegics and mydriatics. Tolerance, habituation, and addiction to topical administration. Arch Ophthalmol1975;93:423-513.
Sato EH, de Freitas D, Foster CS. Abuse of cyclopentolate hydrochloride (Cyclogyl) drops. New Engl J Med 1992; 326: 1363-1364.
Akkaya C, Zorlu Kocagoz S, Sarandol A. Addiction to topically used cyclopentolate hydrochloride: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1752-1753.
Darcin AE, Dilbaz N, Yilmaz S, Cetin MK. Cyclopentolate hydrochloride eye drops addiction: A Case Report. J Addict Med 2011; 5: 84-85.
Miller NS, Guttman JC. The integration of pharmacological therapy for comor- bid psychiatric and addictive disorders. J Psychoactive Drugs 1997; 29: 249-254.
McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420-426.
Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985; 142: 1259-1264.
Thornton LK, Baker AL, Johnson MP, et al. Reasons for substance use among people with psychotic disorders: method triangulation approach. Psychol Addict Behav. 2012; 26: 279-288.
Spencer C, Castle D, Michie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull. 2002; 28: 233-247.
Bersani FS, Corazza O, Simonato P, et al. Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy. Gen Hosp Psychiatry. 2013; 5: 571-573.
Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972; 2: 632-635.
Pettersen H, Ruud T, Ravnda lE, Landheim A.Walk-ing the fine line: self-reported reasons for substance use in persons with severe mental illness. IntJ Qual Stud Health Well-being. 2013; 8: 21968.
Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev. 2006; 30: 215-238.
Lester DB, Rogers TD, Blaha CD. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther. 2010; 16: 137-162.
Weiss RD, Griffin ML, Mirin SM. Drug abuse as self medication for depression: an empirical study. Am J Drug Alcohol Abuse 1992; 18: 121-129.
Fleck DE, Arndt S, DelBello MP, Strakowski SM. Concurrent tracking of alcohol use and bipolar disorder symptoms. Bipolar Disord 2006; 8: 338-344.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Journal of Dependence